Skip to main content
. 2017 May 8;8(35):58754–58764. doi: 10.18632/oncotarget.17678

Table 1. Patient information.

Clinical features No. patients
Age >45y 18
≤ 45y 7
Stage II 8
III-IV 17
History Endometrioid 20
Non-endometrioid 5
Tumor size >4cm 22
≤ 4cm 3
Lymphnode metastasis Positive 15
Negative 10
Differentiation G1-G2 16
G3 9
NAC Sensitive 10
Resistant 15

NAC: neoadjuvant.